165 results
Page 5 of 9
424B2
g5v6lxrgqqx0
13 Jun 14
Prospectus for primary offering
12:00am
F-3
l95h1n3z92us
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
rjpgxp 8fg
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
e2kl1djt24vkxfi
10 Mar 14
BioLineRx Completes Dose Escalation Stage of Phase 1/2 Study
12:00am
424B5
282jv0 vccbw9crd
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
h5nn770swcqzmz
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
pymn3u
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99.1
awx ecnzji
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
ar89ioqqhm
24 Feb 14
BioLineRx Appoints Dr. Sandra Panem to
12:00am
6-K
EX-99
5lkr ji9pnvrxeg9
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
x7i uaev5v6o5
13 Jan 14
Current report (foreign)
12:00am
6-K
EX-99
1uy1rh7 zg
18 Dec 13
Current report (foreign)
12:00am
6-K
EX-99
doi1649u0e bcwwu
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-99
0hi0fgffch2gecqknf
26 Nov 13
Current report (foreign)
12:00am
6-K
EX-99
q8mrs7a7
4 Nov 13
BioLineRx Receives Regulatory Approval to Commence
12:00am
6-K
EX-99
brv5ccx
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
6-K
EX-99
u2wzxmts 6fsyk8
19 Aug 13
BioLineRx Appoints B. J. Bormann to
12:00am
424B3
ht2cijp
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
ilpaqic an0ll3e
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am